Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.

Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation. The impact of the factor V Leiden on the risk of VTE in cancer patients remains uncertain.To...

Full description

Bibliographic Details
Main Authors: Adeline Heraudeau, Aurélien Delluc, Mickaël Le Henaff, Karine Lacut, Christophe Leroyer, Benoit Desrues, Francis Couturaud, Cécile Tromeur
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5959061?pdf=render

Internet

http://europepmc.org/articles/PMC5959061?pdf=render

Similar Items